secwatch.observer — SEC 8-K summary
======================================

Issuer:     Intellia Therapeutics, Inc. (NTLA)
CIK:        0001652130
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001193125-25-031989
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Intellia signs 12-year Cambridge lease for ~147K sq ft; terminates Waltham lease with $78M payment
--------------------------------------------------------------------------------

- New lease at 400 Technology Square, Cambridge: initial 101K sq ft, expandable to ~147K sq ft in two tranches starting Dec 2027.
- Base rent $108/sq ft/year, 3% annual escalations; landlord provides up to $41.5M for tenant improvements.
- Winter Street lease terminated with $78M paid in three installments (Feb 2025, Apr 2025, Jan 2026); no rent due after Jan 2025.
- Lease term 12 years 3 months plus 5-year extension option; occupancy starts Jul 2025, rent begins ~14 months later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652130/000119312525031989/0001193125-25-031989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652130/000119312525031989/d860657d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-031989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer